High-dose reirradiation of head and neck cancer with curative intent

Kenneth Stevens, Amy Britsch, William T. Moss

Research output: Contribution to journalArticle

134 Citations (Scopus)

Abstract

Purpose: This study evaluates the responses of new or recurrent head and neck cancers and the response of associated normal tissues to high dose reirradiation with curative intent. Methods and Materials: From 1964 to 1991, 15 patients with in-field new second head and neck cancers and 85 patients with recurrent head and neck cancers have high-dose reirradiation that overlapped with previously irradiated volumes. Reirradiation was given only to patients with no more than apparent minimal clinical radiation effects from the first radiation course. The reirradiation consisted of external beam only in 82 patients, external beam plus intracavitary or interstitial implant irradiation in 14 patients, and interstitial implant irradiation only in four patients. The combined overlapping dose from both the initial and subsequent irradiation (including brachytherapy) was 69-89 Gy in 14 patients, 90-99 Gy in 15 patients, 100-119 Gy in 27 patients, and 120 Gy or greater in 44 patients. Four patients had areas of overlap that received greater than 180 Gy. Results: The actuarial 5-year survival was 37% for patients with new second primary cancers and17% for patients with recurrent cancers. Loco-regional tumor control was achieved in 67% of the patients with new tumors and in 27% of the patients with recurrent tumors. Nine of the 100 patients developed severe adverse normal tissue effects from the reirradiation. Conclusion: High-dose reirradiation of head and neck cancers can be successful curative treatment in a significant proportion of patients. It is associated with substantial but acceptable risks in properly selected patients.

Original languageEnglish (US)
Pages (from-to)687-698
Number of pages12
JournalInternational journal of radiation oncology, biology, physics
Volume29
Issue number4
DOIs
StatePublished - Jul 1 1994

Fingerprint

Head and Neck Neoplasms
cancer
dosage
Re-Irradiation
tumors
Second Primary Neoplasms
irradiation
Neoplasms
interstitials
Radiation Effects
Brachytherapy
radiation effects

Keywords

  • Head and neck cancer
  • Reirradiation

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

High-dose reirradiation of head and neck cancer with curative intent. / Stevens, Kenneth; Britsch, Amy; Moss, William T.

In: International journal of radiation oncology, biology, physics, Vol. 29, No. 4, 01.07.1994, p. 687-698.

Research output: Contribution to journalArticle

Stevens, Kenneth ; Britsch, Amy ; Moss, William T. / High-dose reirradiation of head and neck cancer with curative intent. In: International journal of radiation oncology, biology, physics. 1994 ; Vol. 29, No. 4. pp. 687-698.
@article{ec7ca80e8499443fa599226f9fdf9843,
title = "High-dose reirradiation of head and neck cancer with curative intent",
abstract = "Purpose: This study evaluates the responses of new or recurrent head and neck cancers and the response of associated normal tissues to high dose reirradiation with curative intent. Methods and Materials: From 1964 to 1991, 15 patients with in-field new second head and neck cancers and 85 patients with recurrent head and neck cancers have high-dose reirradiation that overlapped with previously irradiated volumes. Reirradiation was given only to patients with no more than apparent minimal clinical radiation effects from the first radiation course. The reirradiation consisted of external beam only in 82 patients, external beam plus intracavitary or interstitial implant irradiation in 14 patients, and interstitial implant irradiation only in four patients. The combined overlapping dose from both the initial and subsequent irradiation (including brachytherapy) was 69-89 Gy in 14 patients, 90-99 Gy in 15 patients, 100-119 Gy in 27 patients, and 120 Gy or greater in 44 patients. Four patients had areas of overlap that received greater than 180 Gy. Results: The actuarial 5-year survival was 37{\%} for patients with new second primary cancers and17{\%} for patients with recurrent cancers. Loco-regional tumor control was achieved in 67{\%} of the patients with new tumors and in 27{\%} of the patients with recurrent tumors. Nine of the 100 patients developed severe adverse normal tissue effects from the reirradiation. Conclusion: High-dose reirradiation of head and neck cancers can be successful curative treatment in a significant proportion of patients. It is associated with substantial but acceptable risks in properly selected patients.",
keywords = "Head and neck cancer, Reirradiation",
author = "Kenneth Stevens and Amy Britsch and Moss, {William T.}",
year = "1994",
month = "7",
day = "1",
doi = "10.1016/0360-3016(94)90555-X",
language = "English (US)",
volume = "29",
pages = "687--698",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - High-dose reirradiation of head and neck cancer with curative intent

AU - Stevens, Kenneth

AU - Britsch, Amy

AU - Moss, William T.

PY - 1994/7/1

Y1 - 1994/7/1

N2 - Purpose: This study evaluates the responses of new or recurrent head and neck cancers and the response of associated normal tissues to high dose reirradiation with curative intent. Methods and Materials: From 1964 to 1991, 15 patients with in-field new second head and neck cancers and 85 patients with recurrent head and neck cancers have high-dose reirradiation that overlapped with previously irradiated volumes. Reirradiation was given only to patients with no more than apparent minimal clinical radiation effects from the first radiation course. The reirradiation consisted of external beam only in 82 patients, external beam plus intracavitary or interstitial implant irradiation in 14 patients, and interstitial implant irradiation only in four patients. The combined overlapping dose from both the initial and subsequent irradiation (including brachytherapy) was 69-89 Gy in 14 patients, 90-99 Gy in 15 patients, 100-119 Gy in 27 patients, and 120 Gy or greater in 44 patients. Four patients had areas of overlap that received greater than 180 Gy. Results: The actuarial 5-year survival was 37% for patients with new second primary cancers and17% for patients with recurrent cancers. Loco-regional tumor control was achieved in 67% of the patients with new tumors and in 27% of the patients with recurrent tumors. Nine of the 100 patients developed severe adverse normal tissue effects from the reirradiation. Conclusion: High-dose reirradiation of head and neck cancers can be successful curative treatment in a significant proportion of patients. It is associated with substantial but acceptable risks in properly selected patients.

AB - Purpose: This study evaluates the responses of new or recurrent head and neck cancers and the response of associated normal tissues to high dose reirradiation with curative intent. Methods and Materials: From 1964 to 1991, 15 patients with in-field new second head and neck cancers and 85 patients with recurrent head and neck cancers have high-dose reirradiation that overlapped with previously irradiated volumes. Reirradiation was given only to patients with no more than apparent minimal clinical radiation effects from the first radiation course. The reirradiation consisted of external beam only in 82 patients, external beam plus intracavitary or interstitial implant irradiation in 14 patients, and interstitial implant irradiation only in four patients. The combined overlapping dose from both the initial and subsequent irradiation (including brachytherapy) was 69-89 Gy in 14 patients, 90-99 Gy in 15 patients, 100-119 Gy in 27 patients, and 120 Gy or greater in 44 patients. Four patients had areas of overlap that received greater than 180 Gy. Results: The actuarial 5-year survival was 37% for patients with new second primary cancers and17% for patients with recurrent cancers. Loco-regional tumor control was achieved in 67% of the patients with new tumors and in 27% of the patients with recurrent tumors. Nine of the 100 patients developed severe adverse normal tissue effects from the reirradiation. Conclusion: High-dose reirradiation of head and neck cancers can be successful curative treatment in a significant proportion of patients. It is associated with substantial but acceptable risks in properly selected patients.

KW - Head and neck cancer

KW - Reirradiation

UR - http://www.scopus.com/inward/record.url?scp=0028068203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028068203&partnerID=8YFLogxK

U2 - 10.1016/0360-3016(94)90555-X

DO - 10.1016/0360-3016(94)90555-X

M3 - Article

VL - 29

SP - 687

EP - 698

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 4

ER -